344 related articles for article (PubMed ID: 19811408)
1. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris.
Satyam A; Khandpur S; Sharma VK; Sharma A
Immunol Invest; 2009; 38(6):498-509. PubMed ID: 19811408
[TBL] [Abstract][Full Text] [Related]
2. Cytokine networks in Pemphigus vulgaris: An integrated viewpoint.
Giordano CN; Sinha AA
Autoimmunity; 2012 Sep; 45(6):427-39. PubMed ID: 22686612
[TBL] [Abstract][Full Text] [Related]
3. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
[TBL] [Abstract][Full Text] [Related]
4. Cytokine pattern in blister fluid and sera of patients with pemphigus.
Baroni A; Perfetto B; Ruocco E; Greco R; Criscuolo D; Ruocco V
Dermatology; 2002; 205(2):116-21. PubMed ID: 12218224
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris.
Hertl M; Riechers R
J Dermatol; 1999 Nov; 26(11):748-52. PubMed ID: 10635617
[TBL] [Abstract][Full Text] [Related]
6. Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay.
Eming R; Büdinger L; Riechers R; Christensen O; Bohlen H; Kalish R; Hertl M
Br J Dermatol; 2000 Dec; 143(6):1279-82. PubMed ID: 11122034
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of microRNA-338-3p contributes to production of Dsg3 antibody in pemphigus vulgaris patients.
Liu Q; Cui F; Wang M; Xiong H; Peng X; Liang L; Li L; Zhang J; Peng X; Zeng K
Mol Med Rep; 2018 Jul; 18(1):550-556. PubMed ID: 29749496
[TBL] [Abstract][Full Text] [Related]
8. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease.
Rizzo C; Fotino M; Zhang Y; Chow S; Spizuoco A; Sinha AA
Clin Exp Dermatol; 2005 Sep; 30(5):535-40. PubMed ID: 16045688
[TBL] [Abstract][Full Text] [Related]
9. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris.
Veldman C; Höhne A; Dieckmann D; Schuler G; Hertl M
J Immunol; 2004 May; 172(10):6468-75. PubMed ID: 15128839
[TBL] [Abstract][Full Text] [Related]
10. The imbalance of gut microbiota and its correlation with plasma inflammatory cytokines in pemphigus vulgaris patients.
Huang S; Mao J; Zhou L; Xiong X; Deng Y
Scand J Immunol; 2019 Sep; 90(3):e12799. PubMed ID: 31211854
[TBL] [Abstract][Full Text] [Related]
11. Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris.
Timoteo RP; da Silva MV; Miguel CB; Silva DA; Catarino JD; Rodrigues Junior V; Sales-Campos H; Freire Oliveira CJ
Mediators Inflamm; 2017; 2017():7151285. PubMed ID: 28321152
[TBL] [Abstract][Full Text] [Related]
12. Th1 and Th2 cytokine modulation by IL-10/IL-12 imbalance in autoimmune haemolytic anaemia (AIHA).
Fagiolo E; Toriani-Terenzi C
Autoimmunity; 2002 Feb; 35(1):39-44. PubMed ID: 11908705
[TBL] [Abstract][Full Text] [Related]
13. Low SOCS3 expression in CD4
Lin X; Chen M; Li X; Wang H; Bao Y
Mol Immunol; 2022 Oct; 150():114-125. PubMed ID: 36030709
[TBL] [Abstract][Full Text] [Related]
14. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay.
Komai A; Amagai M; Ishii K; Nishikawa T; Chorzelski T; Matsuo I; Hashimoto T
Br J Dermatol; 2001 Jun; 144(6):1177-82. PubMed ID: 11422038
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
[TBL] [Abstract][Full Text] [Related]
16. Further support for a role for Th2-like cytokines in blister formation of pemphigus.
Caproni M; Giomi B; Cardinali C; Salvatore E; Pestelli E; D'Agata A; Bianchi B; Toto P; Feliciani C; Fabbri P
Clin Immunol; 2001 Feb; 98(2):264-71. PubMed ID: 11161984
[TBL] [Abstract][Full Text] [Related]
17. Study of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial.
El-Darouti MA; Hegazy RA; Abdel Hay RM; El Hawary MS; Tawdy AM; Fawzy MM; Rashed LA
Arch Dermatol Res; 2015 May; 307(4):299-307. PubMed ID: 25450635
[TBL] [Abstract][Full Text] [Related]
18. T helper type 1 polarizing γδ T cells and Scavenger receptors contribute to the pathogenesis of Pemphigus vulgaris.
Das D; Anand V; Khandpur S; Sharma VK; Sharma A
Immunology; 2018 Jan; 153(1):97-104. PubMed ID: 28815581
[TBL] [Abstract][Full Text] [Related]
19. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris.
Takahashi H; Amagai M; Nishikawa T; Fujii Y; Kawakami Y; Kuwana M
J Immunol; 2008 Jul; 181(2):1526-35. PubMed ID: 18606708
[TBL] [Abstract][Full Text] [Related]
20. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.
Nagel A; Lang A; Engel D; Podstawa E; Hunzelmann N; de Pita O; Borradori L; Uter W; Hertl M
Clin Immunol; 2010 Mar; 134(3):320-30. PubMed ID: 20015693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
